Author Topic: (Abst.) Tecfidera better at preventing relapses than Aubagio  (Read 38 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8216
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Tecfidera better at preventing relapses than Aubagio
« on: March 18, 2019, 08:25:17 am »
This study, published in Neurology, showed Tecfidera to be better than Aubagio at preventing relapses and less likely to be discontinued due to disease breakthrough: From PubMed, March 17, 2019--"Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study":


https://www.ncbi.nlm.nih.gov/pubmed/30877188
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
74 Views
Last post May 16, 2017, 12:06:36 pm
by agate
0 Replies
93 Views
Last post September 23, 2017, 04:24:24 pm
by agate
0 Replies
67 Views
Last post June 08, 2018, 09:02:03 pm
by agate
0 Replies
12 Views
Last post May 12, 2019, 11:44:22 am
by agate
0 Replies
16 Views
Last post July 30, 2019, 07:31:49 am
by agate